Science Explorer Interactive view Map
Company · Stockholm · Sweden

Oncopeptides (Sweden)

Research works
40
▲ 813% vs 2013–17
Citations
579
14.5 per fractional work
Top-10% rate
8.6%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: Oncopeptides (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.37× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 0.35× its world share, 0 worksImmunology and Micro…Neuroscience: 0.31× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.70× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.56× its world share, 0 worksChemistryComputer Science: 0.61× its world share, 1 worksComputer ScienceEnvironmental Science: 0.64× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.14× its world share, 0 worksMaterials ScienceMathematics: 1.06× its world share, 0 worksMathematicsHealth Professions: 0.14× its world share, 0 worksHealth ProfessionsMedicine: 2.87× its world share, 7 worksMedicineEconomics, Econometrics and Finance: 0.58× its world share, 0 worksEconomics, Econometr…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.4×. Every wedge is a field page.

Who are the top researchers at Oncopeptides (Sweden)?

Ranked on the composite score, Fredrik Lehmann lead among researchers whose main affiliation is Oncopeptides (Sweden).

  1. 1 Fredrik Lehmann Sweden · #1,505,474 worldwide 20 citations · 22 works
All ranked researchers at Oncopeptides (Sweden)

Which keywords describe research at Oncopeptides (Sweden)?

By fractional works in all years, weighted toward what it does more of than the world: Proteasome Inhibitors, Diagnosis Criteria, International Myeloma Working Group, Cancer Therapy, Angiogenesis, Tumor Microenvironment, PET Imaging and Fibroblast Activation Protein.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Proteasome Inhibitors8▲ 295×2 topics
  2. Diagnosis Criteria7▲ 614×1 topic
  3. International Myeloma Working Group7▲ 614×1 topic
  4. Cancer Therapy7▲ 26×8 topics
  5. Angiogenesis4▲ 25×5 topics
  6. PET Imaging4▲ 41×2 topics
  7. Tumor Microenvironment4▲ 25×2 topics
  8. Fibroblast Activation Protein3▲ 166×1 topic
  9. Immunosuppression3▲ 73×1 topic
  10. Transcriptional Regulation3▲ 33×3 topics
  11. BET Bromodomains3▲ 380×1 topic
  12. PROTACs3▲ 380×1 topic
  13. Cancer3▲ 4.8×6 topics
  14. Drug Discovery2▲ 15×5 topics
  15. Apoptosis2▲ 11×5 topics
  16. Metabolism2▲ 6.5×2 topics
  17. Medicinal Chemistry2▲ 10×6 topics
  18. Protein-Protein Interactions2▲ 35×2 topics
  19. Foldamers1▲ 43×1 topic
  20. Mutation1▲ 22×2 topics
  21. Peptide Synthesis1▲ 43×1 topic
  22. Tumor Suppression1▲ 30×2 topics
  23. Cell Cycle1▲ 57×1 topic
  24. Glycosylation1▲ 15×3 topics
  25. Metastatic Breast Cancer1▲ 48×2 topics
  26. Quality of Life1▲ 2.4×2 topics
  27. p531▲ 76×1 topic
  28. Chemotherapy-Induced Peripheral Neuropathy1▲ 62×1 topic
  29. Taxanes1▲ 62×1 topic
  30. Chemotherapy1▲ 3.8×8 topics
  31. Monoclonal Antibodies1▲ 19×2 topics
  32. Pharmacology1▲ 8.2×3 topics
  33. Therapeutic Antibodies1▲ 22×2 topics
  34. Autism Spectrum Disorders1▲ 29×1 topic
  35. Feeding Problems1▲ 73×1 topic
  36. Growth Hormone1▲ 31×2 topics

Which research topics does Oncopeptides (Sweden) publish most on?

By volume in 2022–2025: Multiple Myeloma Research and Treatments, Cancer-related Molecular Pathways, Protein Degradation and Inhibitors and PI3K/AKT/mTOR signaling in cancer.

  1. 1 Multiple Myeloma Research and Treatments Hematology 4 works
  2. 2 Cancer-related Molecular Pathways Oncology 1 works
  3. 3 Protein Degradation and Inhibitors Molecular Biology 1 works
  4. 4 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
  5. 5 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  6. 6 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 0 works
  7. 7 Chemical Synthesis and Analysis Molecular Biology 0 works
  8. 8 Cancer Treatment and Pharmacology Oncology 0 works
  9. 9 Chemistry and Chemical Engineering Environmental Chemistry 0 works
  10. 10 Peptidase Inhibition and Analysis Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.5%not open54.5%

World: 28% of research is openly available.

with international co-authors67.5%domestic only32.5%

World: 19% is written across borders.

How has Oncopeptides (Sweden)'s research output changed?

Output in 2018–2022 was 813% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Stockholm

All research institutions in Stockholm

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.